Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) hit a new 52-week high on Monday . The company traded as high as GBX 55.95 and last traded at GBX 52, with a volume of 118208 shares traded. The stock had previously closed at GBX 51.34.
Beximco Pharmaceuticals Price Performance
The company has a market cap of £231.98 million, a PE ratio of 0.03 and a beta of 0.25. The firm has a 50 day simple moving average of GBX 43.80 and a 200-day simple moving average of GBX 42.98. The company has a quick ratio of 0.37, a current ratio of 4.13 and a debt-to-equity ratio of 5.27.
About Beximco Pharmaceuticals
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
Featured Articles
- Five stocks we like better than Beximco Pharmaceuticals
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
- The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
- Why Micron Is Doubling Down While the HBM Shortage Persists
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
